Reuters logo
BRIEF-Tetra Bio-Pharma, Intelgenx sign agreement for development, commercialization of Dronabinol XL tablet
April 3, 2017 / 12:15 PM / 6 months ago

BRIEF-Tetra Bio-Pharma, Intelgenx sign agreement for development, commercialization of Dronabinol XL tablet

April 3 (Reuters) - Tetra Bio-pharma Inc:

* Tetra Bio-pharma and Intelgenx announce the signing of a definitive agreement for the development and commercialization of a Dronabinol XL tablet

* Tetra Bio-pharma Inc - definitive agreement follows binding term sheet between two companies that was announced on February 9, 2017

* Tetra Bio-Pharma Inc - pursuant to definitive agreement, Tetra has exclusive rights to sell product in North America

* Tetra Bio-Pharma Inc - Tetra will have a right of first negotiation for territories outside of United States and Canada Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below